Usefulness of procainamide challenge for electrophysiologic arrhythmia risk stratification

Area of Science:

• Cardiology
• Electrophysiology

Background:

• Electrophysiologic testing is crucial for assessing ventricular arrhythmia risk.
• Identifying patients who benefit from implantable cardioverter-defibrillators (ICDs) requires accurate risk stratification.

Purpose of the Study:

• To evaluate the impact of intravenous procainamide on the yield of electrophysiologic testing for ventricular tachycardia induction.
• To determine if procainamide-induced ventricular tachycardia predicts future ventricular arrhythmias requiring ICD intervention.

Main Methods:

• Electrophysiologic testing was performed on 58 patients undergoing ICD implantation.
• Ventricular tachycardia was induced in the baseline state or after intravenous procainamide administration.
• Follow-up assessed ventricular arrhythmias requiring ICD termination.

Main Results:

• Procainamide increased the yield of ventricular tachycardia induction by 49%.
• Patients inducible only with procainamide experienced ventricular arrhythmias requiring ICD termination.
• The positive predictive value of electrophysiologic testing was maintained.

Conclusions:

• Intravenous procainamide enhances the detection rate of sustained ventricular arrhythmias during electrophysiologic testing.
• This provocative approach improves risk assessment for ICD candidates.
• Procainamide use does not diminish the predictive accuracy of the testing.